Highlights
-
PRP for Carpal Tunnel Syndrome: Recent study explores PRP’s safety and potential for nerve regeneration.
-
Protein Concentration in PRP: Dr. Ariana DeMers discusses its impact on treating degenerative joints.
-
Value-Added Services for PRP Practices: Tips to enhance patient satisfaction and retention.
-
Conversations in REGEN: Register for today’s session with Dr. Jason Dragoo.
-
BOB Live at IOF: Save the date for Feb 27, 2025, in Scottsdale, AZ—an event you don’t want to miss!
Today’s Research Article
Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial
Seyed Ahmad Raeissadat, Afshin Karimzadeh, Masoud Hashemi and Leila Bagherzadeh
Summary:
This randomized controlled trial evaluated the safety and efficacy of platelet-rich plasma (PRP) injections in conjunction with wrist splinting versus wrist splinting alone for women with mild to moderate carpal tunnel syndrome (CTS). Over 10 weeks, both groups showed significant improvement in pain, symptom severity, and functional status. However, PRP did not provide significant additional benefits compared to splinting alone in any outcome measures, including electrophysiological parameters. The study highlights PRP’s theoretical potential for nerve regeneration but concludes that its effects may require a longer follow-up period to manifest fully.
The short follow-up duration, small sample size, and lack of a placebo-controlled group limit the study's conclusions. While the trial demonstrated PRP’s safety with minimal side effects, it failed to establish significant advantages over conservative treatments in the short term. The authors recommend further high-quality, long-term studies to explore the delayed effects of PRP and determine its true efficacy in CTS treatment.
Talking Points for Doctors to Patients: Why Choose PRP
